ATLANTA, GA--(Marketwire - July 25, 2008) - AtheroGenics, Inc. (NASDAQ: AGIX), a pharmaceutical company focused on the treatment of chronic inflammatory diseases, today announced that it will release its second quarter 2008 financial results on Tuesday, August 5, 2008 before the U.S. financial markets open.
